Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of American Oncology Network, Inc. (DTOC) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of American Oncology Network, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1839998.
Total stock buying since 2023: $20,682.
Total stock sales since 2023: $2,157,876.
Total stock option exercises since 2023: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2024 | 10,340 | $20,682 | 0 | $0 | 0 | $0 |
2023 | 0 | $0 | 205,512 | $2,157,876 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2024-05 | 10,340 | $20,682 | 0 | $0 | 0 | $0 |
2023-09 | 0 | $0 | 205,512 | $2,157,876 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-05-24 | Divers Stephen (Chief Medical Officer) | Buy | 5,000 | 2.15 | 10,750 |
2024-05-21 | Schonherz Todd (Chief Executive Officer) | Buy | 5,340 | 1.86 | 9,932 |
2023-09-25 | Weinstein Boaz (10% Owner) | Sale | 205,512 | 10.50 | 2,157,876 |
Insider trading activities including stock purchases, stock sales, and option exercises of DTOC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of American Oncology Network, Inc. (symbol DTOC, CIK number 1839998) see the Securities and Exchange Commission (SEC) website.